Benign neoplasm: Urinary organ, other/unspecified

CD2_BENIGN_URINARY_NOS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D30.7&, D30.9& Hospital discharge: ICD-9 — 223[8-9] Hospital discharge: ICD-8 — 223[8-9] Cause of death: ICD-10 — D30.7&, D30.9& Cause of death: ICD-9 — 223[8-9] Cause of death: ICD-8 — 223[8-9] 2 out of 7 registries used, show all original rules.	101
4. Check minimum number of events None	101
5. Include endpoints None	101
6. Filter based on genotype QC (FinnGen only)	96

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	CD2_BENIGN_URINARY_NOS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D30[7\|9]
HD_ICD_9	223[8-9]
HD_ICD_8	223[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D30[7\|9]
COD_ICD_9	223[8-9]
COD_ICD_8	223[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Urinary organ, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	991	579	393
Only index persons	703	426	277
Unadjusted period prevalence (%)
Whole population	0.01	0.02	0.01
Only index persons	0.01	0.02	0.01
Median age at first event (years)
Whole population	58.75	57.59	60.12
Only index persons	53.30	53.31	53.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	96	61	35
Unadjusted period prevalence (%)	0.02	0.02	0.02
Median age at first event (years)	49.06	44.86	56.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
101: Matched controls
1010

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D30.9

ICD-10 Finland

Benign neoplasm: Urinary organ, unspecified

+∞

60.7

22388

ICD-8 Finland

Benign neoplasm of kidney and other urinary organs, Other specified sites

+∞

21.6

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

67.3

10.9

D30.7

ICD-10 Finland

Benign neoplasm: Other urinary organs

+∞

10.6

UKC02

NOMESCO Finland

Cystoscopy

4.5

9.8

22399

ICD-8 Finland

Benign neoplasm of kidney and other urinary organs, Unspecified site

+∞

9.5

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

361

1.99

2.87

13.2

12.7

1.09

1.27

inr

1.09

106

(3030467) Casts [#/volume] in Urine by Automated count

189

2.01

2.54

2.7

3.0

0.23

0.48

e6/l

0.81

148

(3018095) Leukocytes [#/volume] in Urine

255

1.86

2.27

3.1

3.5

141.07

53.23

e6/l

0.43

189

(36304419) Bacteria [Presence] in Urine

189

1.92

2.22

2.7

2.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

308

1.76

2.00

3.6

2.6

115.16

106.13

ug/l

0.13

288

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.80

1.92

14.3

4.9

23.92

25.53

mmol/l

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

181

1.84

1.92

2.2

2.0

2.48

2.96

mg/l

0.72

159

(3002582) Erythrocytes [#/volume] in Urine

216

1.78

1.87

2.7

3.0

25.98

329.73

e6/l

0.55

176

(40761536) Microorganisms panel - Urine sediment

2.26

1.86

5.7

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

104

2.02

1.83

2.7

2.5

2.83

1.03

e6/l

0.52

(1616796) Gas panel - Central venous blood

3.99

1.73

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

3.70

1.63

2.4

1.9

5.02

4.81

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

3.70

1.63

2.4

1.9

8.76

9.14

kpa

—

(3037467) Urinalysis macro (dipstick) panel - Urine

517

1.65

1.59

6.1

4.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2.30

1.57

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

1.95

1.54

1.4

1.5

664.00

577.60

titre

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.13

1.45

1.4

1.6

—

(36660697) Celiac disease serology panel - Serum

2.21

1.44

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

331

1.58

1.42

3.7

35.63

35.28

g/l

0.18

310

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.88

1.42

2.8

2.6

117.26

2.88

e6/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

305

1.58

1.38

2.4

1.9

93.84

98.27

pmol/l

0.27

142

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.95

1.33

3.9

3.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.49

1.26

1.5

2.2

—

(3049717) Cytology report of Urine Cyto stain

2.49

1.26

2.7

2.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

248

1.56

1.23

3.7

2.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

131

1.66

1.10

2.1

1.4

1.92

2.40

g/l

0.45

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.34

1.04

1.6

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.01

0.99

1.4

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.01

0.99

1.9

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

161

1.55

0.98

1.4

1.2

0.48

2.22

u/ml

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.98

0.91

1.3

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.98

0.91

1.5

—

(40761535) Cells panel - Urine sediment

1.78

0.86

6.0

3.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.80

0.0

3.1

—

4.01

—

(3019309) Folate [Moles/volume] in Red Blood Cells

151

1.49

0.79

2.8

1.6

1159.79

1207.52

nmol/l

0.10

118

(3022145) Colonoscopy Study observation

101

1.57

0.75

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

319

1.36

0.74

3.8

3.7

36.40

31.55

ng/l

0.13

226

(3007853) Bacteria identified in Skin by Aerobe culture

1.61

0.73

2.5

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.80

0.73

3.1

1.3

—

(3019225) pH of Specimen

1.67

0.72

15.2

5.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

467

1.34

0.70

6.0

4.0

7.30

6.69

mmol/l

1.14

439

(3012516) Albumin [Mass/volume] in Urine

220

0.68

0.69

3.9

3.1

13.67

26.72

mg/l

—

142

(3000991) Gas panel - Venous blood

1.62

0.62

17.6

5.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

133

1.43

0.60

3.2

2.8

0.83

0.82

mmol/l

0.04

127

(3035350) Ketones [Presence] in Urine by Test strip

367

1.30

0.59

5.6

3.8

0.00

estimate

-0.00

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

566

1.30

0.58

6.2

4.3

14.75

14.89

pmol/l

0.16

512

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.60

0.58

1.2

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

368

1.29

0.57

7.0

5.2

0.00

estimate

-0.00

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.66

0.56

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.45

0.53

6.2

3.9

1.21

1.23

mmol/l

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

101

1.45

0.53

7.1

3.5

1.05

1.00

mmol/l

0.25

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.42

0.52

1.7

—

(3000494) Fungus identified in Specimen by Culture

1.49

0.52

1.2

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

372

1.27

0.52

13.2

6.3

1.21

1.22

mmol/l

0.20

321

(3009261) Glucose [Presence] in Urine by Test strip

372

1.27

0.52

5.5

3.8

0.00

estimate

-0.00

(3013707) Erythrocyte sedimentation rate by Westergren method

572

1.27

0.50

5.7

4.3

12.60

12.46

mm/h

0.03

525

(3044889) 12 lead EKG panel

536

0.80

0.47

4.4

3.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

177

1.31

0.45

1.7

1.6

21.38

20.74

nmol/l

0.04

147

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.44

0.43

1.5

—

(3022313) Gas panel - Capillary blood

1.54

0.42

8.6

3.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.41

0.0

1.9

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.41

0.0

1.9

—

4.12

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.41

0.0

1.9

—

107.53

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.41

0.0

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.40

0.0

2.5

—

17.47

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.45

0.40

1.0

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.41

0.39

7.6

5.3

—

(3026008) Bacteria identified in Urine by Culture

257

1.24

0.38

5.0

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

210

1.25

0.37

7.0

3.8

0.00

estimate

-0.00

(3001604) Monocytes [#/volume] in Blood

384

1.21

0.37

5.1

5.2

0.54

0.58

e9/l

0.45

337

(3014007) Fractional oxyhemoglobin in Arterial blood

1.49

0.37

20.0

6.3

95.73

93.26

—

(3013115) Eosinophils [#/volume] in Blood

394

1.21

0.36

5.0

5.8

0.19

e9/l

0.01

349

(3019198) Lymphocytes [#/volume] in Blood

394

1.21

0.36

5.0

5.3

1.83

1.98

e9/l

0.39

354

(3006315) Basophils [#/volume] in Blood

385

1.20

0.36

5.1

5.2

0.03

0.04

e9/l

0.61

338

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

615

1.21

0.35

9.1

6.9

82.74

76.98

u/l

0.32

575

(46235355) HIV 1 and 2 tests - Meaningful Use set

100

1.34

0.35

1.7

—

(40768797) Stomach Pathology biopsy report

101

1.33

0.33

1.2

—

(3021589) Normoblasts [#/volume] in Blood

339

1.19

0.32

10.7

9.6

0.00

e9/l

0.50

278

(3013512) EKG study

244

1.20

0.30

4.3

3.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

693

1.19

0.29

6.9

5.0

1.75

1.93

mu/l

0.57

621

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

756

1.21

0.27

18.7

13.6

23.29

21.25

mg/l

0.22

617

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

123

1.26

0.27

1.5

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

714

0.85

0.26

4.3

4.1

1.42

1.25

mmol/l

1.14

643

(3041096) Erythrocytes [Presence] in Urine by Automated

220

1.18

0.24

5.1

3.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

298

1.16

0.23

6.5

3.9

—

(3002256) Pathology report gross observation

1.28

0.23

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

741

0.86

0.23

4.8

4.6

1.40

1.51

mmol/l

1.46

677

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.26

0.23

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

239

0.85

0.22

4.9

3.6

7.25

5.25

mg/mmol

0.17

146

(3025941) Bacteria identified in Stool by Culture

1.23

0.22

1.2

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.20

0.22

23.6

6.0

0.50

0.71

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

458

1.14

0.21

8.0

9.6

3.75

4.10

e9/l

0.53

405

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

2.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.2

—

50.67

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

369

1.14

0.21

5.9

5.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.21

0.0

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

713

1.14

0.18

16.7

12.9

78.51

79.12

ml/min/173m2

0.08

580

(1761868) Lipid panel - Serum or Plasma

254

1.14

0.18

3.4

3.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.20

0.18

2.0

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

746

0.88

0.18

4.6

4.7

4.77

4.65

mmol/l

0.48

687

(3012544) pH of Venous blood

1.19

0.17

3.1

2.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

159

1.16

0.16

6.2

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

424

1.11

0.16

6.4

5.6

10.34

10.61

umol/l

0.08

403

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.14

0.15

1.3

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

179

1.15

0.15

2.4

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

131

1.17

0.15

1.2

1.3

61.50

7.83

u/ml

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.21

0.15

12.1

5.6

107.00

103.87

mmol/l

1.33

(3020564) Creatinine [Moles/volume] in Serum or Plasma

800

1.13

0.13

20.9

16.1

82.94

74.90

umol/l

0.85

800

(3019150) Specific gravity of Urine by Refractometry

168

0.87

0.13

8.4

4.0

1.01

1.02

kg/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

105

1.16

0.11

1.9

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.18

0.11

13.4

5.8

5.19

5.23

kpa

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

711

1.10

0.11

7.2

6.0

40.47

40.65

mmol/mol

0.05

659

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.17

0.10

23.6

5.9

0.92

1.64

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

363

1.08

0.09

2.5

2.4

—

(4200892) Spirometry reversibility

1.06

0.08

1.8

1.3

—

(3002032) Base excess in Venous blood by calculation

1.08

0.08

3.3

2.3

-1.19

2.93

mmol/l

—

(4035726) Immunohistochemistry procedure

1.07

0.08

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

764

0.93

0.07

5.3

5.2

2.86

2.71

mmol/l

0.65

695

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

100

0.89

0.06

6.4

7.7

—

(3042936) Bacteria identified in Isolate by Culture

110

1.10

0.05

2.4

1.8

—

(3023368) Bacteria identified in Blood by Culture

219

1.07

0.05

4.6

3.9

—

(40761511) CBC panel - Blood by Automated count

780

0.95

0.04

20.4

13.2

—

(40768804) Tissue Pathology biopsy report

301

1.04

0.03

2.2

2.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

732

1.04

0.02

5.9

4.8

6.12

5.95

mmol/l

0.57

674

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

123

1.07

0.02

1.8

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

144

1.05

0.00

5.6

4.0

20.53

21.01

—

(40758558) Short blood count panel - Blood

204

1.04

0.00

2.4

6.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

443

0.99

0.00

2.9

2.7

—

(3018418) pH of Serum or Plasma

235

0.97

0.00

4.6

3.3

7.36

7.40

—

(3003694) ABO and Rh group [Type] in Blood

191

0.99

0.00

1.7

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

249

1.01

0.00

2.4

2.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

502

0.99

0.00

4.1

2.9

46.71

47.91

u/l

0.04

468

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

188.76

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.00

-0.00

1.4

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

36.60

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.94

-0.00

1.4

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.75

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

6.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.0

—

147.33

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

0.31

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

0.83

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.94

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

14.54

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.96

-0.00

3.2

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.3

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.7

—

819.67

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.58

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

1207.60

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

31.5

—

1561.00

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_URINARY_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_URINARY_NOS	2.076 [1.53, 2.81]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.075

During the follow-up period (1.1.1998 — 31.12.2019), 107 out of 274 females with CD2_BENIGN_URINARY_NOS died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_URINARY_NOS	1.753 [1.16, 2.64]	0.007
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 88 out of 186 males with CD2_BENIGN_URINARY_NOS died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_URINARY_NOS.

N-year risk	Females	Males
1	0.158%	0.392%
5	1.142%	2.311%
10	2.997%	5.351%
15	5.58%	10.066%
20	9.505%	17.181%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_URINARY_NOS – Benign neoplasm: Urinary organ, other/unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Urinary organ, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints